VOLUME 62   2001   SUPPLEMENT 22

Articles

3 Introduction: The Role of Enteric-Coated Fluoxetine Once-Weekly in Achieving Optimal Outcomes in the Long-Term Treatment of Depression. David J. Kupfer
[PDF]

5 The Burden of Recurrent Depression: Causes, Consequences, and Future Prospects. John F. Greden
[Abstract] [PDF]

10 Treatment Recommendations Versus Treatment Realities: Recognizing the Rift and Understanding the Consequences. Ellen Frank and Rajinder Judge
[Abstract] [PDF]

16 Factors Affecting Return of Symptoms 1 Year After Treatment in a 62-Week Controlled Study of Fluoxetine in Major Depression. Frederick W. Reimherr, Robert E. Strong, Barrie K. Marchant, Dawson W. Hedges, and Paul H. Wender
[Abstract] [PDF]

24 Fluoxetine: A Suitable Long-Term Treatment. Helena Maria Calil
[Abstract] [PDF]

30 Compliance With Antidepressants in a Primary Care Setting, 1: Beyond Lack of Efficacy and Adverse Events. Koen Demyttenaere, Paul Enzlin, Walthere Dewe, Bruno Boulanger, Jozef De Bie, Wim De Troyer, and Patrick Mesters
[Abstract] [PDF]

34 Compliance With Antidepressants in a Primary Care Setting, 2: The Influence of Gender and Type of Impairment. Koen Demyttenaere, Paul Enzlin, Walthere Dewe, Bruno Boulanger, Jozef De Bie, Wim De Troyer, and Patrick Mesters
[Abstract] [PDF]

38 Exploring Treatment Alternatives: Weekly Dosing of Fluoxetine for the Continuation Phase of Major Depressive Disorder. William J. Burke and Delores A. McArthur-Miller
[Abstract] [PDF]

43 Patient Compliance With Enteric-Coated Weekly Fluoxetine During Continuation Treatment of Major Depressive Disorder. Erik de Klerk
[Abstract] [PDF]

48 Efficacy and Safety of Weekly Treatment With Enteric-Coated Fluoxetine in Patients With Major Depressive Disorder. Timothy G. Dinan
[Abstract] [PDF]

53 Patient Perspectives on Once-Weekly Fluoxetine. Rajinder Judge
[Abstract] [PDF]